200 related articles for article (PubMed ID: 34642317)
1. Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma.
Bosnakovski D; Ener ET; Cooper MS; Gearhart MD; Knights KA; Xu NC; Palumbo CA; Toso EA; Marsh GP; Maple HJ; Kyba M
Oncogenesis; 2021 Oct; 10(10):68. PubMed ID: 34642317
[TBL] [Abstract][Full Text] [Related]
2. Expression of the CIC-DUX4 fusion oncoprotein mimics human CIC-rearranged sarcoma in genetically engineered mouse models.
Hendrickson PG; Oristian KM; Browne MR; Luo L; Ma Y; Cardona DM; Linardic CM; Kirsch DG
Res Sq; 2023 Oct; ():. PubMed ID: 37961185
[TBL] [Abstract][Full Text] [Related]
3. Expression of the CIC-DUX4 fusion oncoprotein mimics human CIC-rearranged sarcoma in genetically engineered mouse models.
Hendrickson PG; Oristian KM; Browne MR; Lou L; Ma Y; Cardona DM; Linardic CM; Kirsch DG
bioRxiv; 2023 Sep; ():. PubMed ID: 37808628
[TBL] [Abstract][Full Text] [Related]
4. Negative MAPK-ERK regulation sustains CIC-DUX4 oncoprotein expression in undifferentiated sarcoma.
Lin YK; Wu W; Ponce RK; Kim JW; Okimoto RA
Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20776-20784. PubMed ID: 32788348
[TBL] [Abstract][Full Text] [Related]
5.
Yoshimoto T; Tanaka M; Homme M; Yamazaki Y; Takazawa Y; Antonescu CR; Nakamura T
Cancer Res; 2017 Jun; 77(11):2927-2937. PubMed ID: 28404587
[No Abstract] [Full Text] [Related]
6. Spontaneous expression of the CIC::DUX4 fusion oncoprotein from a conditional allele potently drives sarcoma formation in genetically engineered mice.
Hendrickson PG; Oristian KM; Browne MR; Luo L; Ma Y; Cardona DM; Nash JO; Ballester PL; Davidson S; Shlien A; Linardic CM; Kirsch DG
Oncogene; 2024 Apr; 43(16):1223-1230. PubMed ID: 38413794
[TBL] [Abstract][Full Text] [Related]
7. CIC-DUX4 Chromatin Profiling Reveals New Epigenetic Dependencies and Actionable Therapeutic Targets in CIC-Rearranged Sarcomas.
Bakaric A; Cironi L; Praz V; Sanalkumar R; Broye LC; Favre-Bulle K; Letovanec I; Digklia A; Renella R; Stamenkovic I; Ott CJ; Nakamura T; Antonescu CR; Rivera MN; Riggi N
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275898
[TBL] [Abstract][Full Text] [Related]
8. Mapping chromatin state and transcriptional response in CIC-DUX4 undifferentiated round cell sarcoma.
Thomas NJ; Luck C; Shlimon N; Ponce RK; Kosibaty Z; Okimoto RA
bioRxiv; 2023 Oct; ():. PubMed ID: 37873100
[TBL] [Abstract][Full Text] [Related]
9. CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programs.
Okimoto RA; Wu W; Nanjo S; Olivas V; Lin YK; Ponce RK; Oyama R; Kondo T; Bivona TG
J Clin Invest; 2019 Jul; 129(8):3401-3406. PubMed ID: 31329165
[TBL] [Abstract][Full Text] [Related]
10. A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression, and cell death.
Bosnakovski D; da Silva MT; Sunny ST; Ener ET; Toso EA; Yuan C; Cui Z; Walters MA; Jadhav A; Kyba M
Sci Adv; 2019 Sep; 5(9):eaaw7781. PubMed ID: 31535023
[TBL] [Abstract][Full Text] [Related]
11. CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers.
Mancarella C; Carrabotta M; Toracchio L; Scotlandi K
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358827
[TBL] [Abstract][Full Text] [Related]
12. Primary undifferentiated small round cell sarcoma of the deep abdominal wall with a novel variant of t(10;19) CIC-DUX4 gene fusion.
Tsukamoto Y; Futani H; Yoshiya S; Watanabe T; Kihara T; Matsuo S; Hirota S
Pathol Res Pract; 2017 Oct; 213(10):1315-1321. PubMed ID: 28645808
[TBL] [Abstract][Full Text] [Related]
13. Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma.
Carrabotta M; Laginestra MA; Durante G; Mancarella C; Landuzzi L; Parra A; Ruzzi F; Toracchio L; De Feo A; Giusti V; Pasello M; Righi A; Lollini PL; Palmerini E; Donati DM; Manara MC; Scotlandi K
Cancer Res; 2022 Feb; 82(4):708-720. PubMed ID: 34903601
[TBL] [Abstract][Full Text] [Related]
14. Round cell sarcoma with CIC-DUX4 gene fusion: Discussion of the distinctive cytomorphologic, immunohistochemical, and molecular features in the differential diagnosis of round cell tumors.
Chebib I; Jo VY
Cancer Cytopathol; 2016 May; 124(5):350-61. PubMed ID: 26800124
[TBL] [Abstract][Full Text] [Related]
15. DUX4 Immunohistochemistry Is a Highly Sensitive and Specific Marker for CIC-DUX4 Fusion-positive Round Cell Tumor.
Siegele B; Roberts J; Black JO; Rudzinski E; Vargas SO; Galambos C
Am J Surg Pathol; 2017 Mar; 41(3):423-429. PubMed ID: 27879517
[TBL] [Abstract][Full Text] [Related]
16. WEE1 kinase is a therapeutic vulnerability in CIC-DUX4 undifferentiated sarcoma.
Ponce RKM; Thomas NJ; Bui NQ; Kondo T; Okimoto RA
JCI Insight; 2022 Mar; 7(6):. PubMed ID: 35315355
[TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma.
Yoshimatsu Y; Noguchi R; Tsuchiya R; Kito F; Sei A; Sugaya J; Nakagawa M; Yoshida A; Iwata S; Kawai A; Kondo T
Hum Cell; 2020 Apr; 33(2):427-436. PubMed ID: 31898195
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a novel human CIC-DUX
Nakai S; Yamada S; Outani H; Nakai T; Yasuda N; Mae H; Imura Y; Wakamatsu T; Tamiya H; Tanaka T; Hamada K; Tani A; Myoui A; Araki N; Ueda T; Yoshikawa H; Takenaka S; Naka N
Sci Rep; 2019 Nov; 9(1):15812. PubMed ID: 31676869
[TBL] [Abstract][Full Text] [Related]
19. Ewing-like sarcoma with CIC-DUX4 gene fusion in a patient with neurofibromatosis type 1. A hitherto unreported association.
Tardío JC; Machado I; Navarro L; Idrovo F; Sanz-Ortega J; Pellín A; Llombart-Bosch A
Pathol Res Pract; 2015 Nov; 211(11):877-82. PubMed ID: 26386605
[TBL] [Abstract][Full Text] [Related]
20. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation.
Kawamura-Saito M; Yamazaki Y; Kaneko K; Kawaguchi N; Kanda H; Mukai H; Gotoh T; Motoi T; Fukayama M; Aburatani H; Takizawa T; Nakamura T
Hum Mol Genet; 2006 Jul; 15(13):2125-37. PubMed ID: 16717057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
